The Calgary Depression Scale for Schizophrenia is the best instrument for diagnosing depression in schizophrenia

shutterstock_78612907

Depression can be difficult to detect and diagnose and this difficulty only increases when other mental health conditions are also present.

This systematic review conducted by a team of researchers from Groningen in the Netherlands, set out to identify the best instrument for diagnosing depression in people with schizophrenia. Their concern was that some diagnostic tools developed for use in depression patients may not discriminate between depressive symptoms and the negative psychotic symptoms that are often present in schizophrenia.

The researchers conducted a broad search and found 48 papers that measured the reliability and validity of 6 depression instruments for patients with schizophrenia:

  1. Beck Depression Inventory (BDI)
  2. Brief Psychiatric Rating Scale-Depression subscale (BPRS-D)
  3. Positive and Negative Syndrome Scale-Depression subscale (PANSS-D)
  4. Hamilton Rating Scale for Depression (HAMD)
  5. Montgomery Asberg Depression Rating Scale (MADRS)
  6. Calgary Depression Scale for Schizophrenia (CDSS)

The Beck Depression Inventory was the only one of the 6 instruments that used a self-reporting mechanism to measure the extent of the depressive illness. The other 5 were all clinician rated scales.

Here’s what they found with their review:

  • All 6 instruments reliably measured depressive symptoms in patients with schizophrenia
  • The Calgary Depression Scale for Schizophrenia most accurately:
    • differentiated depressive symptoms from other symptoms of schizophrenia (divergent validity)
    • correlated well with other depression instruments (concurrent validity)
    • and was least likely to miss cases of depression or misdiagnose depression (predictive validity)

The authors concluded:

We would recommend to use the Calgary Depression Scale for Schizophrenia for the measurement of depressive symptoms in research and in daily clinical practice of patients with schizophrenia. A valid self-report instrument is to be developed for the use in clinical practice.

Lako IM, Bruggeman R, Knegtering H, Wiersma D, Schoevers RA, Slooff CJ, Taxis K. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. J Affect Disord. 2011 Nov 17. [PubMed abstract]

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Andre Tomlin

Andre Tomlin

André Tomlin is an Information Scientist with 20 years experience working in evidence-based healthcare. He's worked in the NHS, for Oxford University and since 2002 as Managing Director of Minervation Ltd, a consultancy company who do clever digital stuff for charities, universities and the public sector. Most recently André has been the driving force behind the Mental Elf and the National Elf Service; an innovative digital platform that helps professionals keep up to date with simple, clear and engaging summaries of evidence-based research. André is a Trustee at the Centre for Mental Health and an Honorary Research Fellow at University College London Division of Psychiatry. He lives in Bristol with his wife, dog and three little elflings.

More posts - Website

Follow me here –